Literature DB >> 25639449

Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.

Rubi Jeong1, Yoon-Seon Lee, Changhwan Sohn, Jin Jeon, Shin Ahn, Kyoung Soo Lim.   

Abstract

OBJECTIVES: The purposes of this study were to investigate the clinical presentation, cause and outcome of drug-induced liver injury (DILI) and to evaluate the predictive value of the model for end-stage liver disease (MELD) score in DILI.
METHODS: Patients diagnosed with DILI between January 1, 2010 and December 31, 2012 in the Emergency Department at Asan Medical Center in Seoul, Korea were analyzed retrospectively. The primary end point was poor outcome, defined as liver transplantation or death within 30 days of the initial hospital visit.
RESULTS: Of 213 patients, 13.1% had a 30-day poor outcome. Folk remedies were the most common cause of DILI in 147 patients (69%). Univariate logistic regression analysis showed that multiple drugs (odds ratio [OR] 2.30, 95% confidence interval [CI]: 1.03-5.15), concurrent alcohol consumption (OR 3.69, 95% CI: 1.03-13.18), white blood cell (WBC) count (OR 1.17, 95% CI: 1.07-1.28), hemoglobin (Hb) (OR 0.60, 95% CI: 0.49-0.74), platelet count (OR 0.993, 95% CI: 0.987-0.998), total bilirubin (OR 1.09, 95% CI: 1.06-1.13) and MELD (OR 1.23, 95% CI: 1.15-1.32) were significantly associated with 30-day poor outcomes. Multivariate analysis showed that the MELD (OR 1.21, 95% CI: 1.12-1.30) and Hb (OR 0.77, 95% CI: 0.61-0.98) were independent predictors of poor outcome. For 30-day mortality, the c-statistics for MELD alone and for combination of MELD and Hb were 0.93 (95% CI: 0.89-0.97) and 0.94 (95% CI: 0.90-0.97), respectively.
CONCLUSION: The outcome of patients with DILI was poor. MELD score and Hb were reliable predictors of short-term outcome in patients with DILI.

Entities:  

Keywords:  MELD score; drug-induced liver injury; liver transplantation; mortality; prognosis

Mesh:

Substances:

Year:  2015        PMID: 25639449     DOI: 10.3109/00365521.2014.958094

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Authors:  Vincent Lo Re; Kevin Haynes; Kimberly A Forde; David S Goldberg; James D Lewis; Dena M Carbonari; Kimberly B F Leidl; K Rajender Reddy; Melissa S Nezamzadeh; Jason Roy; Daohang Sha; Amy R Marks; Jolanda De Boer; Jennifer L Schneider; Brian L Strom; Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-27       Impact factor: 11.382

2.  Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.

Authors:  A S Mansfield; A J Tafur; D Vulih; G L Smith; P J Harris; S P Ivy
Journal:  Thromb Res       Date:  2015-10-20       Impact factor: 3.944

3.  Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.

Authors:  Nanjegowda Sunil Kumar; Bhavith Remalayam; Varghese Thomas; Thazhath M Ramachandran; Kandiyil Sunil Kumar
Journal:  J Clin Exp Hepatol       Date:  2020-08-20

4.  Liver Injury Associated With Drugs and Complementary and Alternative Medicines in India.

Authors:  Einar S Björnsson
Journal:  J Clin Exp Hepatol       Date:  2021-04-27

5.  CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Authors:  Yue-Cheng Yu; Yi-Min Mao; Cheng-Wei Chen; Jin-Jun Chen; Jun Chen; Wen-Ming Cong; Yang Ding; Zhong-Ping Duan; Qing-Chun Fu; Xiao-Yan Guo; Peng Hu; Xi-Qi Hu; Ji-Dong Jia; Rong-Tao Lai; Dong-Liang Li; Ying-Xia Liu; Lun-Gen Lu; Shi-Wu Ma; Xiong Ma; Yue-Min Nan; Hong Ren; Tao Shen; Hao Wang; Ji-Yao Wang; Tai-Ling Wang; Xiao-Jin Wang; Lai Wei; Qing Xie; Wen Xie; Chang-Qing Yang; Dong-Liang Yang; Yan-Yan Yu; Min-de Zeng; Li Zhang; Xin-Yan Zhao; Hui Zhuang
Journal:  Hepatol Int       Date:  2017-04-12       Impact factor: 6.047

Review 6.  Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.

Authors:  Jing Jing; Rolf Teschke
Journal:  J Clin Transl Hepatol       Date:  2017-10-27

Review 7.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

Review 8.  Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital.

Authors:  Pengcheng Ou; Yi Chen; Chengwei Chen; Baozhen Li; Min Zhang; Xingyu Liu; Fangfang Li; Yi Li; Yimin Mao; Jun Chen
Journal:  Springerplus       Date:  2015-12-22

Review 9.  Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.

Authors:  William R Treem; Melissa Palmer; Isabelle Lonjon-Domanec; Daniel Seekins; Lara Dimick-Santos; Mark I Avigan; John F Marcinak; Ajit Dash; Arie Regev; Eric Maller; Meenal Patwardhan; James H Lewis; Don C Rockey; Adrian M Di Bisceglie; James W Freston; Raul J Andrade; Naga Chalasani
Journal:  Drug Saf       Date:  2020-11-03       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.